Regenerative Med Firm Biostage Promotes La Francesca to President

Saveiro La Francesca, chief medical officer of biotech company Biostage (NASDAQ: [[ticker:BSTG]]), has been promoted to president. La Francesca had served as chief medical officer of the Holliston, MA-based company since 2014. The cardiothoracic surgeon oversaw Biostage’s development and preclinical testing of a technology that uses stem cells to bioengineer organ implants. In his new role, Biostage says La Francesca will oversee testing of this “Cellframe Technology” in clinical trials expected to start later this year.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan